<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a series of 39 cases of acquired idiopathic <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo> accounting for 12 p </plain></SENT>
<SENT sid="1" pm="."><plain>100 of the 330 cases of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> diagnosed in our department in six years </plain></SENT>
<SENT sid="2" pm="."><plain>Patients' mean age was high (70.8 years) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001903'>Anemia</z:hpo> was present in 92 p </plain></SENT>
<SENT sid="4" pm="."><plain>100 of the cases and was of the macrocytic type in 87 p </plain></SENT>
<SENT sid="5" pm="."><plain>100 of the patients </plain></SENT>
<SENT sid="6" pm="."><plain>Only two patients (5 p </plain></SENT>
<SENT sid="7" pm="."><plain>100) had <z:hpo ids='HP_0001875'>neutropenia</z:hpo> and two (5 p </plain></SENT>
<SENT sid="8" pm="."><plain>100) had <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0001894'>Thrombocytosis</z:hpo> was observed in 17 cases (43 p </plain></SENT>
<SENT sid="10" pm="."><plain>100); it was usually moderate </plain></SENT>
<SENT sid="11" pm="."><plain>The mean proportion of medullary ring-sideroblasts was 35 +/- 14 p </plain></SENT>
<SENT sid="12" pm="."><plain>100 </plain></SENT>
<SENT sid="13" pm="."><plain>A clonal abnormality was found in 4 of the 11 karyotype examinations performed </plain></SENT>
<SENT sid="14" pm="."><plain>The course of the disease was marked by recurrences of <z:hpo ids='HP_0001903'>anemia</z:hpo> which required regular blood transfusions in 82 p </plain></SENT>
<SENT sid="15" pm="."><plain>100 of the cases </plain></SENT>
<SENT sid="16" pm="."><plain>In at least 30 p </plain></SENT>
<SENT sid="17" pm="."><plain>100 of the patients followed up for more than 30 months, these transfusions were responsible for <z:e sem="disease" ids="C0238158" disease_type="Disease or Syndrome" abbrv="">secondary haemochromatosis</z:e> </plain></SENT>
<SENT sid="18" pm="."><plain>Conversely, in only three patients (7.5 p </plain></SENT>
<SENT sid="19" pm="."><plain>100) the disease progressed to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="20" pm="."><plain>On the other hand, 4 patients (10 p </plain></SENT>
<SENT sid="21" pm="."><plain>100) developed <z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">thrombocythemia</z:e> (greater than 1,000 x 10(9)/1) </plain></SENT>
<SENT sid="22" pm="."><plain>Median actuarial survival rate was 48 months </plain></SENT>
<SENT sid="23" pm="."><plain>There were only two factors of poor prognosis: age over 70 and <z:hpo ids='HP_0001903'>anemia</z:hpo> with less than 8 g/dl <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> at the time of diagnosis </plain></SENT>
<SENT sid="24" pm="."><plain>Transfusion <z:e sem="disease" ids="C0018995" disease_type="Disease or Syndrome" abbrv="">haemochromatosis</z:e> is the principal risk in acquired idiopathic <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo>: this risk can be prevented by iron chelating agents in patients with frequent blood perfusions </plain></SENT>
</text></document>